精算学如何为卫生技术评估领域做出贡献？一种跨学科视角。
How can actuarial science contribute to the field of health technology assessment? An interdisciplinary perspective.
作者信息
Espinosa Oscar, Drummond Michael, Russo Ellyn, Williams David, Wix Donna
机构信息
Economic Models and Quantitative Methods Research Group (IMEMC), Centro de Investigaciones para el Desarrollo, Universidad Nacional de Colombia, Bogotá, D.C., Colombia.
Centre for Health Economics, University of York, York, UK.
出版信息
Int J Technol Assess Health Care. 2025 Jan 6;41(1):e3. doi: 10.1017/S0266462324004781.
Abstract
A reflective analysis is presented on the potential added value that actuarial science can contribute to the field of health technology assessment. This topic is discussed based on the experience of several experts in health actuarial science and health economics. Different points are addressed, such as the role of actuarial science in health, actuarial judgment, data inputs and their quality, modeling methodologies and the use of decision-analytic models in the age of artificial intelligence, and the development of innovative pricing and payment models.
摘要
本文对精算科学可为健康技术评估领域带来的潜在附加值进行了反思性分析。基于健康精算科学和健康经济学领域多位专家的经验，对这一主题展开了讨论。探讨了不同的要点，如精算科学在健康领域的作用、精算判断、数据输入及其质量、建模方法以及在人工智能时代决策分析模型的应用，还有创新定价和支付模式的发展。
相似文献
1
How can actuarial science contribute to the field of health technology assessment? An interdisciplinary perspective.精算学如何为卫生技术评估领域做出贡献？一种跨学科视角。
Int J Technol Assess Health Care. 2025 Jan 6;41(1):e3. doi: 10.1017/S0266462324004781.
2
Clinical versus actuarial prediction: a review of the literature.临床预测与精算预测：文献综述
Percept Mot Skills. 1992 Oct;75(2):583-94.
3
Artificial intelligence software for analysing chest X-ray images to identify suspected lung cancer: an evidence synthesis early value assessment.人工智能软件分析胸部 X 光图像以识别疑似肺癌：证据综合早期价值评估。
Health Technol Assess. 2024 Aug;28(50):1-75. doi: 10.3310/LKRT4721.
4
Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries.在中东欧国家，使用人工智能方法进行卫生技术评估的障碍。
Front Public Health. 2022 Jul 14;10:921226. doi: 10.3389/fpubh.2022.921226. eCollection 2022.
5
Artificial intelligence for breast cancer detection and its health technology assessment: A scoping review.用于乳腺癌检测的人工智能及其健康技术评估：一项范围综述。
Comput Biol Med. 2025 Jan;184:109391. doi: 10.1016/j.compbiomed.2024.109391. Epub 2024 Nov 22.
6
Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment.克服人工智能驱动的证据在健康技术评估中应用障碍的建议。
Front Public Health. 2023 Apr 26;11:1088121. doi: 10.3389/fpubh.2023.1088121. eCollection 2023.
7
Connecting clinical and actuarial prediction with rule-based methods.运用基于规则的方法连接临床预测与精算预测。
Psychol Assess. 2015 Jun;27(2):636-44. doi: 10.1037/pas0000072. Epub 2015 Feb 2.
8
The Value of Artificial Intelligence for Healthcare Decision Making-Lessons Learned.人工智能在医疗决策中的价值——经验教训
Value Health. 2022 Mar;25(3):328-330. doi: 10.1016/j.jval.2021.12.009. Epub 2022 Jan 31.
9
Multi-criteria decision analysis for health technology assessment in Canada: insights from an expert panel discussion.加拿大卫生技术评估中的多准则决策分析：专家小组讨论的观点。
Expert Rev Pharmacoecon Outcomes Res. 2015 Feb;15(1):13-9. doi: 10.1586/14737167.2015.965155. Epub 2014 Sep 30.
10
Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review.基于人工智能的医疗器械的当前临床研究是否足够全面，足以支持全面的健康技术评估？系统评价。
Artif Intell Med. 2023 Jun;140:102547. doi: 10.1016/j.artmed.2023.102547. Epub 2023 Apr 23.
本文引用的文献
1
Cost analysis of self-monitoring blood glucose in nonintensively managed type 2 diabetes.非强化管理 2 型糖尿病患者自我监测血糖的成本分析。
Am J Manag Care. 2023 Dec;29(12):670-675. doi: 10.37765/ajmc.2023.89422.
2
A Framework for the Fair Pricing of Medicines.药品合理定价框架
Pharmacoeconomics. 2024 Feb;42(2):145-164. doi: 10.1007/s40273-023-01325-z. Epub 2023 Dec 8.
3
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?健康技术评估机构如何应对细胞和基因治疗带来的评估挑战？
BMC Health Serv Res. 2023 May 13;23(1):484. doi: 10.1186/s12913-023-09494-5.
4
Advance Market Commitments (AMC) model application for Colombian purchase strategy of COVID-19 vaccines.预先市场承诺（AMC）模式在哥伦比亚新冠疫苗采购策略中的应用。
Vaccine X. 2022 Dec;12:100197. doi: 10.1016/j.jvacx.2022.100197. Epub 2022 Jul 28.
5
Solving the Evidence Interpretability Crisis in Health Technology Assessment: A Role for Mechanistic Models?解决卫生技术评估中的证据可解释性危机：机制模型能发挥作用吗？
Front Med Technol. 2022 Feb 24;4:810315. doi: 10.3389/fmedt.2022.810315. eCollection 2022.
6
Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact.评估卫生技术评估（HTA）机构的绩效：构建一个多国、多利益相关方和多维度的框架以探索影响机制。
Cost Eff Resour Alloc. 2021 Jul 2;19(1):37. doi: 10.1186/s12962-021-00290-8.
7
Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study.制定医疗保健决策中结构化专家 elicitation 的参考协议：混合方法研究。
Health Technol Assess. 2021 Jun;25(37):1-124. doi: 10.3310/hta25370.
8
Health technology assessment: a framework.卫生技术评估：一个框架。
RMD Open. 2020 Nov;6(3). doi: 10.1136/rmdopen-2020-001289.
9
The new definition of health technology assessment: A milestone in international collaboration.新的健康技术评估定义：国际合作的里程碑。
Int J Technol Assess Health Care. 2020 Jun;36(3):187-190. doi: 10.1017/S0266462320000215. Epub 2020 May 13.
10
Augmented Intelligence: Enhancing the Roles of Health Actuaries and Health Economists for Population Health Management.增强智能：提升健康精算师和健康经济学家在人群健康管理中的作用。
Popul Health Manag. 2018 Oct;21(5):341-343. doi: 10.1089/pop.2017.0146. Epub 2017 Oct 24.
Zotero 插件